JPWO2019147152A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019147152A5 JPWO2019147152A5 JP2020560859A JP2020560859A JPWO2019147152A5 JP WO2019147152 A5 JPWO2019147152 A5 JP WO2019147152A5 JP 2020560859 A JP2020560859 A JP 2020560859A JP 2020560859 A JP2020560859 A JP 2020560859A JP WO2019147152 A5 JPWO2019147152 A5 JP WO2019147152A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- seq
- antibody according
- nos
- stn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT110526 | 2018-01-26 | ||
| PT110526A PT110526B (pt) | 2018-01-26 | 2018-01-26 | Anticorpo, fragmento funcional ou sonda do mesmo contra antigénios tumorais |
| PCT/PT2019/000001 WO2019147152A1 (en) | 2018-01-26 | 2019-01-17 | L2a5 antibody or functional fragment thereof against tumour antigens |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021516254A JP2021516254A (ja) | 2021-07-01 |
| JPWO2019147152A5 true JPWO2019147152A5 (https=) | 2022-02-24 |
| JP2021516254A5 JP2021516254A5 (https=) | 2022-02-24 |
| JP7324777B2 JP7324777B2 (ja) | 2023-08-10 |
Family
ID=65244573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020560859A Active JP7324777B2 (ja) | 2018-01-26 | 2019-01-17 | 腫瘍抗原に対するｌ２ａ５抗体またはその機能的断片 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US11353460B2 (https=) |
| EP (1) | EP3743726B1 (https=) |
| JP (1) | JP7324777B2 (https=) |
| CN (1) | CN113287018B (https=) |
| AU (1) | AU2019211035B2 (https=) |
| BR (1) | BR112020014931A2 (https=) |
| CA (1) | CA3089300A1 (https=) |
| EA (1) | EA202091760A1 (https=) |
| IL (1) | IL276208B1 (https=) |
| MX (1) | MX2020007828A (https=) |
| PT (1) | PT110526B (https=) |
| SG (1) | SG11202006897VA (https=) |
| WO (1) | WO2019147152A1 (https=) |
| ZA (1) | ZA202005023B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4310100A4 (en) * | 2021-03-18 | 2025-05-14 | Hirosaki University | MONOCLONAL ANTIBODY THAT SPECIFICALLY BINDS TO A SUGAR CHAIN IN WHICH A TERMINAL SIALIC ACID RESIDUE IS BOUND TO GALACTOSE WITH A α2,6 LINKAGE AND METHOD FOR MEASURING THE SUGAR CHAIN WITH A TERMINAL SIALIC ACID RESIDUE BOUND TO GALACTOSE WITH A α2,6 LINKAGE |
| US20240197882A1 (en) * | 2021-04-20 | 2024-06-20 | Ramot At Tel-Aviv University Ltd. | Humanized anti-sialyl-tn glycan antibodies and uses thereof |
| GB2619976A (en) | 2022-06-24 | 2023-12-27 | Cellmabs S A | Humanised antibodies or functional fragments thereof against tumour antigens |
| CN121219019A (zh) | 2023-05-05 | 2025-12-26 | 百欧恩泰欧洲股份公司 | 用于增强靶向癌症相关抗原的采用新型连接子-有效载荷系统的抗体药物偶联物 |
| WO2026057354A1 (en) * | 2024-09-10 | 2026-03-19 | Invox Pharma Limited | Anti-sialyl-tn antigen-binding proteins |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU584417B2 (en) | 1985-04-01 | 1989-05-25 | Lonza Group Ag | Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same |
| GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
| ATE123066T1 (de) * | 1988-03-11 | 1995-06-15 | Biomembrane Inst | Monoklonale antikörper und herstellung eines impfstoffes gegen menschliche krebsantigene durch immunisierung mit menschlichem und tierischem mucin und mit synthetischen gluciden- trägerkonjugaten. |
| CA2189356A1 (en) | 1994-05-02 | 1995-11-09 | Ting Chi Wong | Process for preparation of glycosides of tumor-associated carbohydrate antigens |
| EP0996455B1 (en) | 1997-04-16 | 2009-12-16 | Sloan-Kettering Institute For Cancer Research | Alpha-o-linked glycoconjugates with clustered (2,6)-st epitopes, methods of preparation and uses thereof |
| CU22731A1 (es) * | 1998-02-05 | 2002-02-28 | Centro Inmunologia Molecular | Anticuerpo monoclonal que reconoce el oligosacárido ácido siálico n´glicolilado-galactosa-glucosa (ngcneu-gal-glu) en tumores malignos y composiciones farmacéuticas que los contienen |
| JP3809277B2 (ja) | 1998-03-05 | 2006-08-16 | 生化学工業株式会社 | Ｎ−アセチルグルコサミン−６−ｏ−硫酸基転移酵素のポリペプチド及びそれをコードするｄｎａ |
| GB9917012D0 (en) | 1999-07-20 | 1999-09-22 | Pharmacia & Upjohn Spa | Combined preparations comprising antitumor agents |
| EP1651955A4 (en) | 2003-07-15 | 2007-11-21 | Univ California | PROCESS FOR THE DETECTION AND ANALYSIS OF N-GLYCOLYLNEURAMIC ACID (NEU5GC) IN BIOLOGICAL MATERIALS |
| US8148335B2 (en) | 2004-06-23 | 2012-04-03 | Children's Hospital & Research Center Oakland | De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy |
| EP2083868A2 (en) | 2006-10-04 | 2009-08-05 | Københavns Universitet | Generation of a cancer-specific immune response toward muc1 and cancer specific muc1 antibodies |
| JP5156887B2 (ja) * | 2007-02-14 | 2013-03-06 | 独立行政法人科学技術振興機構 | ２−６シアリル６−スルホ糖鎖に対する抗体 |
| EP2014302A1 (en) | 2007-07-12 | 2009-01-14 | Institut Curie | An antibody specific for the Tn antigen for the treatment of cancer |
| FI20070853A0 (fi) * | 2007-11-09 | 2007-11-09 | Glykos Finland Oy | Glykaania sitovat monoklonaaliset vasta-aineet |
| EP2287202A1 (en) | 2009-08-07 | 2011-02-23 | Dublin City University | Anti-sialic acid antibody molecules |
| EP2524233A4 (en) | 2010-01-15 | 2013-07-31 | Univ California | COMPOSITIONS AND METHOD FOR DETECTING CANCER |
| JP6172687B2 (ja) | 2013-05-02 | 2017-08-02 | 国立研究開発法人産業技術総合研究所 | シアリル化糖鎖を認識するモノクローナル抗体 |
| WO2014191128A1 (en) | 2013-05-29 | 2014-12-04 | Cellectis | Methods for engineering t cells for immunotherapy by using rna-guided cas nuclease system |
| KR102313341B1 (ko) | 2013-08-26 | 2021-10-18 | 바이오엔테크 리서치 앤드 디벨롭먼트 인코포레이티드 | 시알릴-루이스 ａ에 대한 사람 항체 코드화 핵산 |
| EP2990416B1 (en) | 2014-08-29 | 2018-06-20 | GEMoaB Monoclonals GmbH | Universal chimeric antigen receptor expressing immune cells for targeting of diverse multiple antigens and method of manufacturing the same and use of the same for treatment of cancer, infections and autoimmune disorders |
| US20180280504A1 (en) * | 2014-10-10 | 2018-10-04 | Siamab Therapeutics, Inc. | Glycan-interacting compounds and methods of use |
| US11279769B2 (en) * | 2015-08-31 | 2022-03-22 | Helixmith Co., Ltd | Anti-Sialyl Tn chimeric antigen receptors |
| EP3645703B1 (en) * | 2017-05-25 | 2025-11-26 | Instituto de Patologia e Imunologia da Universidade do Porto (IPATIMUP) | Detection and isolation of cancer cells from body fluids based on a glycosylation pattern and methods of use thereof |
-
2018
- 2018-01-26 PT PT110526A patent/PT110526B/pt active IP Right Grant
-
2019
- 2019-01-17 CN CN201980022395.6A patent/CN113287018B/zh active Active
- 2019-01-17 SG SG11202006897VA patent/SG11202006897VA/en unknown
- 2019-01-17 BR BR112020014931-4A patent/BR112020014931A2/pt unknown
- 2019-01-17 US US16/964,900 patent/US11353460B2/en active Active
- 2019-01-17 AU AU2019211035A patent/AU2019211035B2/en active Active
- 2019-01-17 CA CA3089300A patent/CA3089300A1/en active Pending
- 2019-01-17 IL IL276208A patent/IL276208B1/en unknown
- 2019-01-17 MX MX2020007828A patent/MX2020007828A/es unknown
- 2019-01-17 EP EP19702492.0A patent/EP3743726B1/en active Active
- 2019-01-17 EA EA202091760A patent/EA202091760A1/ru unknown
- 2019-01-17 JP JP2020560859A patent/JP7324777B2/ja active Active
- 2019-01-17 WO PCT/PT2019/000001 patent/WO2019147152A1/en not_active Ceased
-
2020
- 2020-08-13 ZA ZA2020/05023A patent/ZA202005023B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7235256B2 (ja) | 重症熱性血小板減少症候群ウイルスの外膜糖タンパク質に結合する抗体及びその用途 | |
| JP2021516254A5 (https=) | ||
| CN112574307A (zh) | 抗人Claudin18.2抗体及其应用 | |
| JP2006020633A (ja) | 糸球体腎炎および他の炎症性疾患の治療のための組成物および方法 | |
| IL273196B2 (en) | Claudin6 antibodies and methods of treating cancer | |
| JP2020522261A5 (https=) | ||
| JP2010523096A (ja) | 抗ＥｐＣＡＭ抗体およびその使用 | |
| CN112513094A (zh) | 结合人her2的抗体、其制备方法和用途 | |
| EP3954999B1 (en) | Compositions and methods for detecting and treating ovarian cancer | |
| CN112094348B (zh) | 抗人Tim3抗体或其功能性片段及其应用 | |
| CN113227148B (zh) | 抗gpc3抗体、其抗原结合片段及其医药用途 | |
| RU2020113713A (ru) | Слитый белок, содержащий молекулу fgf-18 | |
| CN114591434A (zh) | 抗Siglec15抗体及其制备方法和用途 | |
| US9090994B2 (en) | Antibody humanization by framework assembly | |
| JPWO2019147152A5 (https=) | ||
| CN109021103B (zh) | 抗人血管内皮生长因子的抗体及其制备方法和应用 | |
| JP2020521752A (ja) | グロボｈに対するヒト化抗体および癌治療におけるその使用 | |
| CN118206657B (zh) | 一种半乳糖凝集素-3的抗体及其应用 | |
| CN110642947A (zh) | 抗人cd147的单克隆抗体、表达载体、细胞株及其应用 | |
| CN114874318B (zh) | 一种ng-2免疫组织化学抗体 | |
| CN115850477B (zh) | 一种抗人4-1bb单克隆抗体及其应用 | |
| CN116621983A (zh) | 抗robo1人源化抗体、其抗原结合片段及其应用 | |
| WO2011010717A1 (ja) | 抗ｐｓｋ抗体 | |
| CN114685654A (zh) | 一种抗fgf21羧基末端的抗体及其应用 | |
| KR20230124280A (ko) | 메르스 코로나 바이러스의 뉴클레오캡시드 단백질에 특이적인 진단용 항체 및 이의 용도 |